CN108117535A - 萘并[2,3-b]呋喃-4,9-二酮衍生物的制备方法 - Google Patents
萘并[2,3-b]呋喃-4,9-二酮衍生物的制备方法 Download PDFInfo
- Publication number
- CN108117535A CN108117535A CN201711386960.6A CN201711386960A CN108117535A CN 108117535 A CN108117535 A CN 108117535A CN 201711386960 A CN201711386960 A CN 201711386960A CN 108117535 A CN108117535 A CN 108117535A
- Authority
- CN
- China
- Prior art keywords
- reaction
- furans
- naphtho
- preparation
- derovatives
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 0 *c1ccc(C2C(C(c(cccc3)c3C3=O)=O)=C3OC2(O)[Zn])cc1 Chemical compound *c1ccc(C2C(C(c(cccc3)c3C3=O)=O)=C3OC2(O)[Zn])cc1 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D307/92—Naphthofurans; Hydrogenated naphthofurans
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
本发明公开了一种萘并[2,3‑b]呋喃‑4,9‑二酮衍生物的制备方法,包括以下步骤:在25 mL圆底烧瓶中加入不同种类的2‑氨基‑5,10‑氧代‑4‑芳基‑5,10‑二氢‑4H‑苯并[g]苯并吡喃‑3‑腈和N‑氯代丁二酰亚胺以及无水乙醇,在室温下搅拌,TLC检测反应完全;反应结束后,减压除去溶剂,以乙酸乙酯、石油醚为淋洗剂柱层析。本发明方法的反应原料廉价易得,反应条件温和,节约能源,环境友好,反应选择性好,副反应少,易于纯化,收率高。
Description
技术领域
本发明涉及一种萘并[2,3-b]呋喃-4,9-二酮衍生物的制备方法。
背景技术
萘并[2,3-b]呋喃-4,9-二酮衍生物存在与许多天然产物中,具有重要的生物活性。例如,(S)-8-羟基-2-(1-羟基乙基)萘并[2,3-b]呋喃-4,9-二酮(化合物1)存在于腊肠树中,具有较好的抗癌活性。2-甲基萘并[2,3-b]呋喃-4,9-二酮(化合物2) 对日本脑炎病毒显示出较好的抗病毒活性。
现有文献中对萘并[2,3-b]呋喃-4,9-二酮衍生物的制备方法,归纳如下:
1)以4-氨基萘并呋喃衍生物为原料,在3当量亚硝基过硫酸钾和3当量磷酸二氢钾作用下,以丙酮和水为溶剂,在室温条件下反应2小时制得:
该方法的起始原料较难获得,且需要使用大量的氧化剂和助剂,产生较多的副产物。
2)以2-羟基-1,4-萘醌和查尔酮为原料,在1当量N-碘代丁二酰亚胺(NIS) 和2当量1,4-二氮杂二环[2.2.2]辛烷(DABCO)作用下,以乙腈为溶剂,在100℃条件下反应12小时制得:
该方法反应时间较长,反应条件较为苛刻,溶剂乙腈具有一定的毒性,且沸点为82℃,在100℃条件下反应,存在一定的安全隐患。
3)以2-羟基-1,4-萘醌、醛和异腈为原料,以甲苯为溶剂,在回流条件下反应4-48小时制得:
该方法使用的起始原料中的异腈组分价格昂贵,不易获得,溶剂甲苯具有一定的毒性,反应的温度较高,且需要回流时间较长。
发明内容
本发明的目的在于:提供一种萘并[2,3-b]呋喃-4,9-二酮衍生物的制备方法,该制备方法反应条件温和、副反应少、收率高、成本低。
本发明的技术解决方案是该萘并[2,3-b]呋喃-4,9-二酮衍生物的制备方法包括以下步骤:
步骤1:在25mL圆底烧瓶中加入1.0mmol的2-氨基-5,10-氧代-4-芳基-5,10-二氢-4H-苯并[g]苯并吡喃-3-腈和2mmol的N-氯代丁二酰亚胺以及无水乙醇2mL,在室温下搅拌,TLC检测反应完全;
步骤2:反应结束后,减压除去溶剂,以乙酸乙酯、石油醚为淋洗剂柱层析。
进一步的,所述步骤1中的2-氨基-5,10-氧代-4-芳基-5,10-二氢-4H-苯并[g] 苯并吡喃-3-腈中的芳基包括3-氰基苯基,4-甲基苯基,4-溴苯基和4-硝基苯基。
本发明的优点是:1、反应原料廉价易得;2、反应条件温和,节约能源,环境友好;3、反应选择性好,副反应少,易于纯化,收率高。
具体实施方式
下面结合具体实施例进一步说明本发明的技术解决方案,这些实施例不能理解为是对技术方案的限制。
实施例1:
步骤1:在25mL圆底烧瓶中加入2-氨基-5,10-氧代-4-(3-氰基苯基)-5,10-二氢-4H-苯并[g]苯并吡喃-3-腈(1.0mmol)和N-氯代丁二酰亚胺(2.0mmol)以及无水乙醇2mL,在室温下搅拌,TLC检测反应完全;
步骤2:反应结束后,减压除去溶剂,以乙酸乙酯、石油醚为淋洗剂柱层析,得2-氰基-2-甲酸乙酯基-3-(3-氰基苯基)-2,3,4,9-四氢萘并[2,3-b]呋喃-4,9-二酮,
产率:93%;浅黄色固体;
红外光谱(KBr,ν,cm-1):2236,1773,1686,1661,1651,1593, 1373,1353,1245;
核磁共振氢谱(CDCl3,400MHz)(δ,ppm):8.14-8.01(m,2H, Ar-H),7.92-7.88(m,5H,Ar-H),7.69(t,J=7.6Hz,1H,Ar-H),5.67(s,1H,CH),4.42 (dd,J=7.2Hz,2H,CH2),1.34(t,J=7.2Hz,3H,CH3);
核磁共振碳谱(CDCl3,100MHz)(δ,ppm):180.7,176.4,163.0, 159.4,137.3,135.1,134.7,134.5,133.3,133.2,132.7,132.1,130.6,126.5,126.3, 123.2,118.8,113.1,112.4,85.8,65.2,54.9,14.1.
实施例2:
步骤1:在25mL圆底烧瓶中加入2-氨基-5,10-氧代-4-(4-甲基苯基)-5,10-二氢 -4H-苯并[g]苯并吡喃-3-腈(1.0mmol)和N-氯代丁二酰亚胺(2.0mmol)以及无水乙醇2mL,在室温下搅拌,TLC检测反应完全;
步骤2:反应结束后,减压除去溶剂,以乙酸乙酯、石油醚为淋洗剂柱层析,得2-氰基-2-甲酸乙酯基-3-(4-甲基苯基)-2,3,4,9-四氢萘并[2,3-b]呋喃-4,9-二酮,
产率:90%;黄色固体;
红外光谱(KBr,ν,cm-1):1758,1683,1654,1643,1593,1374, 1352,1274;
核磁共振氢谱(CDCl3,400MHz)(δ,ppm):8.09(d,J=8.0Hz,1H, Ar-H),7.90-7.86(m,3H,Ar-H),7.36(d,J=7.6Hz,2H,Ar-H),7.22(d,J=7.6Hz,2H, ArH),5.46(s,1H,CH),4.43-4.36(m,2H,CH2),2.33(s,3H,CH3),1.32(t,J=7.2Hz, 3H,CH3);
核磁共振碳谱(CDCl3,100MHz)(δ,ppm):180.7,176.4,163.4, 158.7,138.8,135.1,134.4,132.7,132.6,132.0,129.9,129.3,126.5,126.3,124.3, 113.2,86.1,65.0,55.5,21.3,14.1.
实施例3:
步骤1:在25mL圆底烧瓶中加入2-氨基-5,10-氧代-4-(4-溴苯基)-5,10-二氢-4H-苯并[g]苯并吡喃-3-腈(1.0mmol)和N-氯代丁二酰亚胺(2.0mmol)以及无水乙醇2mL,在室温下搅拌,TLC检测反应完全;
步骤2:反应结束后,减压除去溶剂,以乙酸乙酯、石油醚为淋洗剂柱层析,得2-氰基-2-甲酸乙酯基-3-(4-溴苯基)-2,3,4,9-四氢萘并[2,3-b]呋喃-4,9-二酮,
产率:97%;浅黄色固体;
红外光谱(KBr,ν,cm-1):1762,1694,1685,1660,1594,1491, 1375,1347,1293,1251;
核磁共振氢谱(CDCl3,400MHz)(δ,ppm):8.10-7.86(m,5H, Ar-H),7.64(d,J=8.0Hz,2H,Ar-H),7.50(d,J=8.0Hz,2H,Ar-H),5.57(s,1H,CH), 4.43-4.39(m,2H,CH2),1.33(t,J=6.8Hz,3H,CH3);
核磁共振碳谱(CDCl3,100MHz)(δ,ppm):180.7,176.3,163.2, 159.1,135.1,135.0,134.4,132.7,132.3,132.0,131.8,126.5,126.3,123.7,122.9, 113.1,85.8,65.1,55.0,14.1.
实施例4:
步骤1:在25mL圆底烧瓶中加入2-氨基-5,10-氧代-4-(4-硝基苯基)-5,10-二氢 -4H-苯并[g]苯并吡喃-3-腈(1.0mmol)和N-氯代丁二酰亚胺(2.0mmol)以及无水乙醇2mL,在室温下搅拌,TLC检测反应完全;
步骤2:反应结束后,减压除去溶剂,以乙酸乙酯、石油醚为淋洗剂柱层析,得2-氰基-2-甲酸乙酯基-3-(4-硝基苯基)-2,3,4,9-四氢萘并[2,3-b]呋喃-4,9-二酮,
产率:80%;浅黄色固体;
红外光谱(KBr,ν,cm-1):1750,1685,1654,1643,1592,1560, 1528,1347,1292;
核磁共振氢谱(CDCl3,400MHz)(δ,ppm):8.30(d,J=8.8Hz,2H, Ar-H),8.11(d,J=6.0Hz,1H,Ar-H),7.91-7.86(m,5H,Ar-H),5.79(s,1H,CH), 4.44-4.42(m,2H,CH2),1.34(t,J=6.8Hz,3H,CH3);
核磁共振碳谱(CDCl3,100MHz)(δ,ppm):180.7,176.3,162.9, 159.3,148.4,142.8,135.2,134.5,132.6,132.0,131.3,126.6,126.3,124.3,123.4, 113.1,85.5,65.2,54.9,14.1。
Claims (2)
1.萘并[2,3-b]呋喃-4,9-二酮衍生物的制备方法,其特征是该制备方法包括以下步骤:
步骤1:在25mL圆底烧瓶中加入1.0 mmol的2-氨基-5,10-氧代-4-芳基-5,10-二氢-4H-苯并[g]苯并吡喃-3-腈和2.0 mmol的N-氯代丁二酰亚胺以及无水乙醇2 mL,在室温下搅拌,TLC检测反应完全;
步骤2:反应结束后,减压除去溶剂,以乙酸乙酯、石油醚为淋洗剂柱层析。
2.根据权利要求1所述的萘并[2,3-b]呋喃-4,9-二酮衍生物的制备方法,其特征是:所述步骤(1)中的2-氨基-5-氧代-4-芳基-4,5-二氢吡喃[3,2-c]苯并吡喃-3-氰基中的芳基包括3-氰基苯基,4-甲基苯基,4-溴苯基4-硝基苯基。
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201711386960.6A CN108117535A (zh) | 2017-12-20 | 2017-12-20 | 萘并[2,3-b]呋喃-4,9-二酮衍生物的制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201711386960.6A CN108117535A (zh) | 2017-12-20 | 2017-12-20 | 萘并[2,3-b]呋喃-4,9-二酮衍生物的制备方法 |
Publications (1)
Publication Number | Publication Date |
---|---|
CN108117535A true CN108117535A (zh) | 2018-06-05 |
Family
ID=62230699
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201711386960.6A Pending CN108117535A (zh) | 2017-12-20 | 2017-12-20 | 萘并[2,3-b]呋喃-4,9-二酮衍生物的制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN108117535A (zh) |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104672224A (zh) * | 2013-11-27 | 2015-06-03 | 广东东阳光药业有限公司 | 二氢嘧啶衍生物的制备方法及其中间体 |
CN106163284A (zh) * | 2014-02-07 | 2016-11-23 | 北京强新生物科技有限公司 | 3‑取代的羰基萘并[2,3‑b]呋喃衍生物或其药学上可接受的盐 |
WO2017164379A1 (ja) * | 2016-03-25 | 2017-09-28 | 大日本住友製薬株式会社 | 2-アルキルカルボニルナフト[2,3-b]フラン-4,9-ジオンの関連物質の製造方法、及びその関連物質 |
-
2017
- 2017-12-20 CN CN201711386960.6A patent/CN108117535A/zh active Pending
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104672224A (zh) * | 2013-11-27 | 2015-06-03 | 广东东阳光药业有限公司 | 二氢嘧啶衍生物的制备方法及其中间体 |
CN106163284A (zh) * | 2014-02-07 | 2016-11-23 | 北京强新生物科技有限公司 | 3‑取代的羰基萘并[2,3‑b]呋喃衍生物或其药学上可接受的盐 |
WO2017164379A1 (ja) * | 2016-03-25 | 2017-09-28 | 大日本住友製薬株式会社 | 2-アルキルカルボニルナフト[2,3-b]フラン-4,9-ジオンの関連物質の製造方法、及びその関連物質 |
Non-Patent Citations (4)
Title |
---|
ASHOK KALE等: "One pot oxidative N–S bon2-sulfenylimine chromenesd formation to access", 《ORGANIC & BIOMOLECULAR CHEMISTRY》 * |
MADHU CHENNAPURAM等: "Group-assisted purification (GAP) chemistry for dihydrofurans: water as a medium for catalyst free synthesis in a one pot four component reaction", 《GREEN CHEMISTRY》 * |
SANTHOSH REDDY MANDHA等: ""One-pot" access to dihydrofurans via tandem oxidative difunctionalization and ring contraction of aminopyrans", 《ORGANIC & BIOMOLECULAR CHEMISTRY》 * |
TUYET ANH DANG THI等: "Expedient stereoselective synthesis of new dihydropyrano- and dihydrofuranonaphthoquinones", 《TETRAHEDRON LETTERS》 * |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Maity et al. | Organocatalytic asymmetric Michael/hemiacetalization/acyl transfer reaction of α-nitroketones with o-hydroxycinnamaldehydes: synthesis of 2, 4-disubstituted chromans | |
Bigdeli et al. | P-Dodecylbenzenesulfonic acid (DBSA), a Brønsted acid-surfactant catalyst for Biginelli reaction in water and under solvent free conditions | |
Rao et al. | AgOTf-catalyzed reactions of naphthols/substituted phenols with 2-hydroxychalcones: facile synthesis of di-aromatic ring-fused [3.3. 1] bicyclic compounds | |
Wang et al. | Rh (III)-catalyzed aldehyde C–H bond functionalization of salicylaldehydes with arylboronic acids | |
Huple et al. | Gold-catalyzed diastereoselective [2+ 2+ 2]-cycloaddition of 1, 7-enynes with carbonyl compounds | |
Chiou et al. | Alkyne-mediated domino hydroformylation/double cyclization: mechanistic insight and synthesis of (±)-tashiromine | |
Moghaddam et al. | Synthesis of Novel Polycyclic Indole‐Annulated Thiopyranocoumarin Derivatives via Domino Knoevenagel–Hetero‐Diels–Alder Reaction in Aqueous Media | |
Liu et al. | Regioselective Synthesis of Aurone Derivatives via PBu3‐Catalyzed Cyclization of 2‐Alkynoylphenols | |
Wang et al. | Annulations of 5-Phenylthiobutenolides and First Synthesis of (±)-Indanostatin | |
Wu et al. | HClO 4–SiO 2-catalyzed synthesis of 12-aryl-12 H-benzo [i][1, 3] dioxolo [4, 5-b] xanthene-6, 11-diones and 10-aryl-6, 7, 8, 10-tetrahydro-7, 7-dimethyl-9 H-[1, 3] dioxolo [4, 5-b] xanthen-9-ones | |
Nandre et al. | CsF mediated rapid condensation of 1, 3-cyclohexadione with aromatic aldehydes: comparative study of conventional heating vs. ambient temperature | |
CN109574972A (zh) | 一种3-烷基取代-4-色满酮类化合物及其制备方法 | |
CN110003231B (zh) | 1,1-螺降冰片烷-吡喃并[4,3-b]色酮类化合物及其制备方法和应用 | |
CN102690239B (zh) | 一种1,5-苯并二氮卓类衍生物的合成方法 | |
Das et al. | Perchloric Acid–Silica (HClO4⋅ SiO2)‐Catalyzed Synthesis of 14‐Alkyl‐or 14‐Aryl‐14H‐dibenzo [a, j] xanthenes and N‐[(2‐Hydroxynaphthalen‐1‐yl) methyl] amides | |
Besra et al. | Copper (II) tetrafluoroborate as an extremely efficient catalyst for 1, 3-dithiolane/dithiane formation from carbonyl compounds under solvent-free conditions at room temperature | |
CN108117535A (zh) | 萘并[2,3-b]呋喃-4,9-二酮衍生物的制备方法 | |
Bellezza et al. | Aza-Diels–Alder reaction of Danishefsky's diene with immines catalyzed by porous α-zirconium hydrogen phosphate and SDS under solvent-free conditions | |
CN103664821A (zh) | 一种基于邻氨基苯硫酚环化的苯并噻唑类化合物制备方法 | |
Krishna et al. | First stereoselective total synthesis of phomonol via oxa-Michael approach | |
CN105777679A (zh) | 一种苯并二氢吡喃环衍生物及其制备方法 | |
Chen et al. | Synthesis of 2, 3, 5, 6-tetrahydro-1-alkyl/aryl-1 H-benzo [f] chromen-3-ol derivatives from β-tetralones and α, β-unsaturated aldehydes | |
CN104860836A (zh) | 一种氧化1,3-二羰基化合物的亚甲基成酮的方法 | |
CN109320488B (zh) | 一种3-羟基黄酮及其衍生物的水相一锅合成方法 | |
Lemus et al. | Lewis acid catalyzed enlargement of cyclic β‐alkoxyenals and one‐pot synthesis of polyfunctional enoxysilanes derived from aucubin with trimethylsilyldiazomethane |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
RJ01 | Rejection of invention patent application after publication |
Application publication date: 20180605 |
|
RJ01 | Rejection of invention patent application after publication |